20-18142268-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001392073.1(KAT14):c.-393C>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.000112 in 1,537,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
KAT14
NM_001392073.1 5_prime_UTR_premature_start_codon_gain
NM_001392073.1 5_prime_UTR_premature_start_codon_gain
Scores
1
6
11
Clinical Significance
Conservation
PhyloP100: 6.14
Genes affected
KAT14 (HGNC:15904): (lysine acetyltransferase 14) CSRP2 is a protein containing two LIM domains, which are double zinc finger motifs found in proteins of diverse function. CSRP2 and some related proteins are thought to act as protein adapters, bridging two or more proteins to form a larger protein complex. The protein encoded by this gene binds to one of the LIM domains of CSRP2 and contains an acetyltransferase domain. Although the encoded protein has been detected in the cytoplasm, it is predominantly a nuclear protein. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2011]
PET117 (HGNC:40045): (PET117 cytochrome c oxidase chaperone) Predicted to be involved in mitochondrial cytochrome c oxidase assembly. Located in mitochondrion. Implicated in cytochrome-c oxidase deficiency disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31744236).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KAT14 | NM_001392073.1 | c.-393C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/11 | ENST00000688188.1 | NP_001379002.1 | ||
PET117 | NM_001164811.2 | c.157C>T | p.Arg53Cys | missense_variant | 2/2 | ENST00000432901.4 | NP_001158283.1 | |
KAT14 | NM_001392073.1 | c.-393C>T | 5_prime_UTR_variant | 2/11 | ENST00000688188.1 | NP_001379002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KAT14 | ENST00000688188 | c.-393C>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/11 | NM_001392073.1 | ENSP00000508684.1 | ||||
PET117 | ENST00000432901.4 | c.157C>T | p.Arg53Cys | missense_variant | 2/2 | 1 | NM_001164811.2 | ENSP00000397881.2 | ||
KAT14 | ENST00000688188 | c.-393C>T | 5_prime_UTR_variant | 2/11 | NM_001392073.1 | ENSP00000508684.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152112Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000493 AC: 7AN: 141868Hom.: 0 AF XY: 0.0000659 AC XY: 5AN XY: 75876
GnomAD3 exomes
AF:
AC:
7
AN:
141868
Hom.:
AF XY:
AC XY:
5
AN XY:
75876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000116 AC: 160AN: 1384848Hom.: 0 Cov.: 30 AF XY: 0.0000907 AC XY: 62AN XY: 683344
GnomAD4 exome
AF:
AC:
160
AN:
1384848
Hom.:
Cov.:
30
AF XY:
AC XY:
62
AN XY:
683344
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74430
GnomAD4 genome
AF:
AC:
12
AN:
152230
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.157C>T (p.R53C) alteration is located in exon 2 (coding exon 2) of the PET117 gene. This alteration results from a C to T substitution at nucleotide position 157, causing the arginine (R) at amino acid position 53 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
D
Sift4G
Uncertain
D
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at